- Conjugation
- transformation
- transduction
- Chemically Competent Cells
- Electrocompetent Cells
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid creation
- Cre-lox recombination (PIR1/PIR2)
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
-
North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
- Market Forecast for 2024-2030
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End user/application Analysis
Competent Cells Market Analysis & Forecast 2024-2030
Competent Cells Market by Type (Chemically Competent Cells, Electrocompetent Cells ) by Application /End User(Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded DNA Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)) by Competence (Natural Competence, Artificial Competence ) Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)
Global Competent Cells Market is expected to reach USD 2777.89 million by 2030 with CAGR of 8.4% between 2024 and 2030
Competent cells incorporate foreign DNA through altered cell walls to pass DNA more easily. Calcium chloride and Heat shock treatment are used to make cell AucompetentAu. Electroporation is a process that includes brief exposure of cells to an electric field to pass DNA through it. Cells undergoing very rapid growth can be made competent easily than cells in other development phase. Bacterial culture has varies growth rate, in initial hours called lag phase with small number of dividing cells growth rate is low. In rapid growth phase also called Log phase under proper temperature cells can become competent easily.
Competent Cells Market: Competence Type
Competence is distinguished based on the environment used to perform on bacterial cell transformation .Basically Competence type are:
Natural Competence
Cells are able to receive DNA from their environment by :
In transformation the DNA is directly pass into the cell. In order to receive transforming DNA recipient cells should be in a specialized physiological state called log phase or competent state.
Artificial Competence
Artificial competence includes setting specific artificial conditions in which cells are made permeable to DNA in laboratory. It is relatively easy competence procedure and can be used in the genetic engineering of bacteria. Artificial competence is low efficiency process as cells are forces to adopt foreign DNA.
Competent Cells Market: Growth Outlook
Technological advancement and increasing need of genomic and protein expressed products are prime factors contributing to growth of Competent Cells Market.
Competent Cells Market: Product Type
Competent Cells Market : Application
Global Competent Cells Market: Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Global Competent Cells Market:
Geographical analysis of Competent Cells Market:
Global Competent Cells Market Report delivers a comprehensive analysis of the following parameters:
Report Coverage
| Parameters | Details |
|---|---|
Base Year |
2023 |
Historical Data |
2018-2023 |
Forecast Data |
2024-2030 |
Base Year Value (2023) |
USD 1344.16 million |
Forecast Value (2030) |
USD 2777.89 million |
CAGR (2022 to 2028) |
8.4 % |
Regional Scope |
North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW |
Frequently Asked Questions (FAQ)
Competent Cells Market was valued at around USD 1344.16 million in 2023 & estimated to reach USD 2777.89 million by 2030.
Competent Cells Market is likely to grow at compounded annual growth rate (CAGR) of 8.4% between 2024 to 2030.
North America accounts for the largest industry share for Competent Cells Market in 2023.
Some of the top companies included in the research report are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen.
Technological advancement and increasing need of genomic and protein expressed products are prime factors contributing to growth of Competent Cells Market.
Yes, the report includes COVID 19 impact on the market.
We are committed to offering 100 % free customization while purchasing.